AG
MRTX

Artal Group’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Hold
0
126
2023
Q4
Sell
-2,024,226
Closed -$88.2M 113
2023
Q3
$88.2M Sell
2,024,226
-30,955
-2% -$1.35M 3.78% 3
2023
Q2
$74.3M Buy
2,055,181
+517,472
+34% +$18.7M 2.3% 5
2023
Q1
$57.2M Sell
1,537,709
-295,049
-16% -$11M 3.4% 7
2022
Q4
$83M Buy
1,832,758
+507,758
+38% +$23M 4.64% 3
2022
Q3
$92.5M Buy
1,325,000
+225,000
+20% +$15.7M 3.95% 2
2022
Q2
$73.8M Sell
1,100,000
-250,000
-19% -$16.8M 3.94% 7
2022
Q1
$111M Sell
1,350,000
-50,000
-4% -$4.11M 4.65% 5
2021
Q4
$205M Buy
1,400,000
+200,000
+17% +$29.3M 5.57% 3
2021
Q3
$212M Buy
1,200,000
+350,000
+41% +$61.9M 4.75% 4
2021
Q2
$137M Buy
850,000
+125,000
+17% +$20.2M 2.79% 7
2021
Q1
$124M Buy
725,000
+225,000
+45% +$38.5M 2.19% 7
2020
Q4
$110M Hold
500,000
2.36% 7
2020
Q3
$83M Buy
+500,000
New +$83M 2.02% 10
2019
Q4
Sell
-200,000
Closed -$15.6M 102
2019
Q3
$15.6M Buy
200,000
+50,000
+33% +$3.9M 0.62% 26
2019
Q2
$15.5M Sell
150,000
-25,000
-14% -$2.58M 0.62% 29
2019
Q1
$12.8M Buy
+175,000
New +$12.8M 0.52% 34
2018
Q1
Sell
-100,000
Closed -$1.83M 123
2017
Q4
$1.83M Buy
+100,000
New +$1.83M 0.03% 63
2015
Q3
Sell
-61,276
Closed -$1.93M 67
2015
Q2
$1.93M Sell
61,276
-188,724
-75% -$5.94M 0.08% 41
2015
Q1
$7.33M Hold
250,000
0.34% 33
2014
Q4
$4.63M Hold
250,000
0.16% 34
2014
Q3
$4.38M Hold
250,000
0.16% 28
2014
Q2
$5M Hold
250,000
0.2% 26
2014
Q1
$4.77M Buy
250,000
+75,000
+43% +$1.43M 0.17% 25
2013
Q4
$2.91M Buy
+175,000
New +$2.91M 0.1% 28